Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Non-Small Cell Lung Cancer
NCT00399789Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Sep 2004
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in non-small cell lung cancer (NSCLC), sponsored by COSCIENS Biopharma Inc.. Started Sep 2004; status: completed.
02
Drugs
perifosine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00399789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399789.